Enovis Corporation

NYSE:ENOV

Medical - Devices

Healthcare
$27.10 +3.50%

+$0.73 today

Market cap
$1.56B
Beta
1.49
P/E (TTM)
-1.1
EPS (TTM)
-$20.02
52W Low $20.55High $36.82

Volume 0.88M

Average 0.99M

ENOV EBITDA Margin

EBITDA as a percentage of revenue.

Enovis CorporationNYSE: ENOV

EBITDA Margin · Q1 FY2026 · quarter ended Apr 2026

EBITDA Margin widens to 15.8%

EBITDA Margin was 15.8% in Q1 FY2026, up 11.6 pp from a year earlier. On a trailing-twelve-month basis it was -32.8%, down 10.9 pp year over year. Over 3 fiscal years it narrowed by 52.4 pp.

Context

  • EBITDA Margin widened in 0 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 9 analysts of 26.1% for the fiscal year ending Dec 2026, up from -36.9% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterApr 2026
15.8%+89.6 pp QoQ
Last fiscal yearDec 2025
-36.9%-14.1 pp YoY
LTMApr 2026
-32.8%-10.9 pp YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+11.6 pp+16.0 pp+4.3 pp
1 year-14.1 pp+63.0 pp+77.1 pp
3 years-52.4 pp+60.3 pp+112.7 pp
5 years——
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2025
-36.9%
Year-over-year change
-14.1pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA Margin vs competitors

How ENOV compares with its peers on the latest reported figures

  • ENOV's LTM Apr 2026 EBITDA Margin of -32.8% is the lowest of the 16 companies compared; the peer median is 18.5%.
  • Its year-over-year change of -10.9 pp is the 15th highest of 16, against a peer median of -0.7 pp.
  • Over three fiscal years its change of -52.4 pp compares with a peer median of -0.9 pp.
ENOV Competitors Peer median
EBITDA Margin for ENOV and competitors
Company Period LTM level YoY 3-year change
IEXIDEX CorporationLTM Jun 202626.7% +1.1 pp-2.5 pp
EPACEnerpac Tool Group Corp.LTM Feb 202622.3% -0.5 pp+15.3 pp
WTSWatts Water Technologies, Inc.LTM Jun 202621.6% +1.0 pp+3.2 pp
KAIKadant Inc.LTM Jul 202620.1% -0.6 pp-2.9 pp
ITTITT Inc.LTM Jul 202619.6% -3.3 pp+2.0 pp
HLIOHelios Technologies, Inc.LTM Jul 202619.1% +1.1 pp-3.9 pp
OFLXOmega Flex, Inc.LTM Mar 202618.7% -5.3 pp-4.6 pp
GRCThe Gorman-Rupp CompanyLTM Jun 202618.5% +0.8 pp+7.2 pp
NPOEnPro Industries, Inc.LTM Jun 202616.3% -6.8 pp+1.8 pp
DCIDonaldson Company, Inc.LTM Jul 202616.0% -0.7 pp-0.9 pp
FELEFranklin Electric Co., Inc.LTM Sep 202615.3% +3.2 pp-2.0 pp
LXFRLuxfer Holdings PLCLTM Mar 20269.6% -2.4 pp-4.9 pp
GHMGraham CorporationLTM Mar 20269.2% -0.9 pp+4.4 pp
MIDDThe Middleby CorporationLTM Jul 2026-0.6% -20.5 pp+1.7 pp
HURCHurco Companies, Inc.LTM Apr 2026-4.7% -1.4 pp-11.6 pp
ENOVEnovis CorporationLTM Apr 2026-32.8% -10.9 pp-52.4 pp
Peer median (excluding ENOV) 18.5%-0.7 pp-0.9 pp

Competitors are the stored peer set for ENOV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.43B1.56B1.71B2.11B2.25B
Cost of Revenue648.51M693.72M716.42M926.87M902.79M
Gross Profit777.68M869.38M990.78M1.18B1.35B
Gross Margin54.5%55.6%58.0%56.0%59.8%
Research & Development49.09M60.83M75.33M91.3M120.33M
Selling, General & Admin665.78M772.91M830.31M939.36M1.07B
Operating Expenses840.47M940.56M1.06B1.96B1.36B
Depreciation & Amortization262.92M219.71M217.11M284.8M294.38M
EBITDA170.25M241.69M169.73M(481.03M)(830.22M)
EBITDA Margin11.9%15.5%9.9%-22.8%-36.9%
Operating Income(62.8M)(71.18M)(65.71M)(775.72M)(18.87M)
Operating Margin-4.4%-4.6%-3.8%-36.8%-0.8%
Interest Income0200K000
Interest Expense29.11M24.95M19.75M57.1M34.82M
Other Income / Expenses(58.98M)69.11M(1.42M)(47.21M)(1.14B)
Income Before Tax(121.78M)(2.07M)(67.13M)(822.92M)(1.16B)
Pre-Tax Margin-8.5%-0.1%-3.9%-39.0%-51.6%
Income Tax Expense(19.53M)36.12M(13.29M)4.49M22.29M
Net Income71.66M(13.29M)(33.26M)(825.49M)(1.18B)
Net Margin5.0%-0.9%-1.9%-39.2%-52.7%
EPS (Basic)(2.02)(0.28)(0.61)(14.93)(20.86)
EPS (Diluted)(2.02)(0.28)(0.61)(14.93)(20.86)
Weighted Avg Shares51.14M54.07M54.53M55.28M56.79M
Weighted Avg Shares (Diluted)51.14M54.07M54.49M55.28M56.79M

Enovis Corporation

NYSE:ENOV

Intrinsic Alpha fair value

Locked

Current Price

$27.10

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.